Creation of human tumour cells with defined genetic elements
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
During malignant transformation, cancer cells acquire genetic mutations that override the normal mechanisms controlling cellular proliferation. Primary rodent cells are efficiently converted into tumorigenic cells by the coexpression of cooperating oncogenes. However, similar experiments with human cells have consistently failed to yield tumorigenic transformants, indicating a fundamental difference in the biology of human and rodent cells. The few reported successes in the creation of human tumour cells have depended on the use of chemical or physical agents to achieve immortalization, the selection of rare, spontaneously arising immortalized cells, or the use of an entire viral genome. We show here that the ectopic expression of the telomerase catalytic subunit (hTERT) in combination with two oncogenes (the simian virus 40 large-T oncoprotein and an oncogenic allele of H-ras) results in direct tumorigenic conversion of normal human epithelial and fibroblast cells. These results demonstrate that disruption of the intracellular pathways regulated by large-T, oncogenic ras and telomerase suffices to create a human tumor cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“expression of telomerase in conjunction with expression of simian virus 40 large T oncoprotein and an oncogenic allele of H-ras has been shown to promote tumorigenic conversion of normal human cells (28).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [28]
In the citing paper
“Interestingly, high telomerase expression, which is associated with long telomeres, is commonly found in adult stem/progenitor cell compartments, including the stem cells in hair follicles, whereas low telomerase expression has been detected in human fibroblasts and epithelial cells [115, 116].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [116]
In the citing paper
“In studies employing a p53 allele (R172P) capable of enforcing senescence but defective in apoptosis, dysfunctional telomeres strongly inhibited the spontaneous lymphomas and sarcomas to which p53-mutant mice normally succumb.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“However, the R172P allele was not as efficient as wild-type p53 in inhibiting chemically induced papillomas”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“suggesting that senescence was insufficient to block transformation of keratinocytes in this model (94).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Self-citationA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Kim, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.13.2595 · Cited by 686
Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., et al. (1999) · Nature Genetics · doi:10.1038/5056 · Cited by 668
Research works printed but not linked: 1
- Kang, J.-S.et al. Involvement of tyrosine phosphorylation of p185c-erb/neu in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinogen.21, 225–233 (1998). · DOI
Cited by
Items 301–400 of 1,011
A Novel Class of Anticancer Compounds Targets the Actin Cytoskeleton in Tumor Cells
Stehn, J. R., Haass, N. K., Bonello, T., Desouza, M., Kottyan, G., Treutlein, H., Zeng, J., Nascimento, P. R. B. B., Sequeira, V. B., Butler, T. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4501 · Cited by 169
Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles
Kim, E., Ilic, N., Shrestha, Y., Zou, L., Kamburov, A., Zhu, C., Yang, X., Lubonja, R., Tran, N., Nguyen, C., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0160 · Cited by 169
Self-citationTumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design
Diaz-Cano, S. J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021951 · Cited by 169
Meza‐Zepeda, L. A., Noer, A., Dahl, J. A., Micci, F., Myklebost, O., & Collas, P. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00146.x · Cited by 169
Su, Z.-Z., Lebedeva, I. V., Sarkar, D., Gopalkrishnan, R. V., Sauane, M., Sigmon, C., Yacoub, A., Valerie, K., Dent, P., & Fisher, P. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206062 · Cited by 168
Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis
White, M. K., & Khalili, K. (2004) · Virology · doi:10.1016/j.virol.2004.03.025 · Cited by 167
Li, B., Yuan, M., Kim, I.-A., Chang, C.-M., Bernhard, E. J., & Shu, H.-K. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207602 · Cited by 168
García-Mata, R., & Burridge, K. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.11.004 · Cited by 165
RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?
Downward, J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2180 · Cited by 166
The role of c-myc in regulation of translation initiation
Schmidt, E. V. (2004) · Oncogene · doi:10.1038/sj.onc.1207548 · Cited by 166
Reversible Immortalization of Human Primary Cells by Lentivector-Mediated Transfer of Specific Genes
Salmon, P., Oberholzer, J., Occhiodoro, T., Morel, P., Lou, J., & Trono, D. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0141 · Cited by 165
Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase
Kharbanda, S., Kumar, V., Dhar, S., Pandey, P., Chen, C., Majumder, P., Yuan, Z.-M., Whang, Y., Strauss, W., Pandita, T. K., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00483-8 · Cited by 165
Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos
Lu, C.-W., Yabuuchi, A., Chen, L., Viswanathan, S., Kim, K., & Daley, G. Q. (2008) · Nature Genetics · doi:10.1038/ng.173 · Cited by 164
DNA replication fidelity and cancer
Preston, B. D., Albertson, T. M., & Herr, A. J. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.009 · Cited by 160
“[232].”
BackgroundTropomyosin isoforms and reagents
Schevzov, G., Whittaker, S. P., Fath, T., Lin, J. J.-C., & Gunning, P. W. (2011) · BioArchitecture · doi:10.4161/bioa.1.4.17897 · Cited by 162
Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway
Wang, Y., Engels, I. H., Knee, D. A., Nasoff, M., Deveraux, Q. L., & Quon, K. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00113-8 · Cited by 161
Ye, X., Zerlanko, B., Zhang, R., Somaiah, N., Lipinski, M., Salomoni, P., & Adams, P. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01592-06 · Cited by 162
Chen, W., Arroyo, J. D., Timmons, J. C., Possemato, R., & Hahn, W. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1103 · Cited by 159
“injected s.c. into immunodeficient mice as described ( 1 ).”
Self-citationRetractedTransformation of normal human cells in the absence of telomerase activation
Seger, Y. R., Garcı́a-Cao, M., Piccinin, S., Cunsolo, C. L., Doglioni, C., Blasco, M. A., Hannon, G. J., & Maestro, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00183-6 · Cited by 159
Unger, C., Kramer, N., Walzl, A., Scherzer, M., Hengstschläger, M., & Dolznig, H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.015 · Cited by 158
Wu, Z.-Q., Guo, Q.-L., You, Q.-D., Zhao, L., & Gu, H.-Y. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1769 · Cited by 158
Telomerase in cancer and aging
Granger, M. P., Wright, W. E., & Shay, J. W. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00188-3 · Cited by 159
Gabelica, V., Baker, E. S., Teulade‐Fichou, M., Pauw, E. D., & Bowers, M. T. (2007) · Journal of the American Chemical Society · doi:10.1021/ja065989p · Cited by 157
Extra-telomeric Functions of Human Telomerase: Cancer, Mitochondria and Oxidative Stress
Saretzki, G. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140630095606 · Cited by 156
Watanabe, H., Soejima, K., Yasuda, H., Kawada, I., Nakachi, I., Yoda, S., Naoki, K., & Ishizaka, A. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-15 · Cited by 154
Inhibition of telomerase activity by HDV ribozyme in cancers
Lu, Y., Gu, J., Jin, D., Gao, Y., & Yuan, M. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-1 · Cited by 161
Of mice and men: hybridoma and recombinant antibodies
Little, M., Kipriyanov, S. M., Gall, F. L., & Moldenhauer, G. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01668-6 · Cited by 160
Telomerase, senescence and ageing
Shawi, M., & Autexier, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.007 · Cited by 170
Wang, L., Wakisaka, N., Tomlinson, C. C., DeWire, S. M., Krall, S. P., Pagano, J. S., & Damania, B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3653 · Cited by 172
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo
Adkins, H. B., Bianco, C., Schiffer, S. G., Rayhorn, P., Zafari, M., Cheung, A. E., Orozco, O., Olson, D., De Luca, A., Chen, L. L., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17788 · Cited by 158
Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
Zhang, A., Zheng, C., Lindvall, C. J., Hou, M., Ekedahl, J., Lewensohn, R., Yan, Z.-Q., Yang, X., Henriksson, M., Blennow, E., et al. (2000) · PubMed · Cited by 186
Telomerase as a universal tumor-associated antigen for cancer immunotherapy
Vonderheide, R. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205074 · Cited by 175
Carcinogenesis in mouse and human cells: parallels and paradoxes
Balmain, A., & C.Harris, C. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.371 · Cited by 155
Genetic reconstruction of individual colorectal tumor histories
Tsao, J.-L., Yatabe, Y., Salovaara, R., Järvinen, H. J., Mecklin, J.-P., Aaltonen, L. A., Tavaré, S., & Shibata, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1236 · Cited by 154
Proteostatic Control of Telomerase Function through TRiC-Mediated Folding of TCAB1
Freund, A., Zhong, F. L., Venteicher, A. S., Meng, Z., Veenstra, T. D., Frydman, J., & Artandi, S. E. (2014) · Cell · doi:10.1016/j.cell.2014.10.059 · Cited by 153
Jiang, F., Bao, J., Li, P., Nicosia, S. V., & Bai, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410395200 · Cited by 152
Ma, N.-F., Hu, L., Fung, J. M., Xie, D., Zheng, B.-J., Chen, L., Tang, D.-J., Fu, L., Wu, Z., Chen, M., et al. (2008) · Hepatology · doi:10.1002/hep.22072 · Cited by 151
Telomerase and human tumorigenesis
Stewart, S. A., & Weinberg, R. A. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0339 · Cited by 169
Self-citationTelomerase regulation: not just flipping the switch
Aisner, D. L., Wright, W. E., & Shay, J. W. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00268-4 · Cited by 171
Rare Codons Regulate KRas Oncogenesis
Lampson, B. L., Pershing, N. L. K., Prinz, J. A., Lacsina, J. R., Marzluff, W. F., Nicchitta, C. V., MacAlpine, D. M., & Counter, C. M. (2013) · Current Biology · doi:10.1016/j.cub.2012.11.031 · Cited by 148
Self-citationEpigenetic Regulation of Cellular Senescence and Aging
Sidler, C., Kovalchuk, O., & Kovalchuk, I. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00138 · Cited by 150
Human Growth Hormone-regulated HOXA1 Is a Human Mammary Epithelial Oncogene
Zhang, X., Zhu, T., Chen, Y., Mertani, H. C., Lee, K.-O., & Lobie, P. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212050200 · Cited by 150
Telomere maintenance and cancer ? look, no telomerase
Neumann, A. A., & Reddel, R. R. (2002) · Nature reviews. Cancer · doi:10.1038/nrc929 · Cited by 183
Oh, S., Song, Y., Yim, J., & Kim, T. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37473 · Cited by 148
Inflammatory signaling and cellular senescence
Ren, J.-L., Pan, J.-S., Lu, Y.-P., Sun, P., & Han, J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 148
Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth
Pazolli, E., Luo, X., Brehm, S., Carbery, K., Chung, J.-J., Prior, J. L., Doherty, J., Demehri, S., Salavaggione, L., Piwnica-Worms, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2970 · Cited by 147
Telomeres, telomerase, and myc. An update
Cerni, C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00091-5 · Cited by 160
Modelling cancer in human skin tissue
Khavari, P. A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1838 · Cited by 175
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
Luraghi, P., Reato, G., Cipriano, E., Sassi, F., Orzan, F., Bigatto, V., De Bacco, F., Menietti, E., Han, M., Rideout, W. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2340-t · Cited by 146
“Weinberg, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, (18).”
BackgroundCancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
Sanjiv, K., Hagenkort, A., Calderón‐Montaño, J. M., Koolmeister, T., Reaper, P. M., Mortusewicz, O., Jacques, S. A., Kuiper, R., Schultz, N., Scobie, M., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.12.032 · Cited by 156
Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands
Cuenca, F., Greciano, O., Gunaratnam, M., Haider, S. M., Munnur, D., Nanjunda, R. K., Wilson, W. D., & Neidle, S. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.050 · Cited by 151
Rich, J. N., Shi, Q., Hjelmeland, M., Cummings, T. J., Kuan, C.-T., Bigner, D. D., Counter, C. M., & Wang, X.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211498200 · Cited by 147
Self-citationZheng, H., Li, L. L., Hu, D. S., Deng, X., & Cao, Y. (2007) · PubMed · Cited by 166
Mechanisms of MYC stabilization in human malignancies
Junttila, M. R., & Westermarck, J. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5492 · Cited by 144
A cell‐based model system links chromothripsis with hyperploidy
Mardin, B. R., Drainas, A. P., Waszak, S. M., Weischenfeldt, J., Isokane, M., Stütz, A. M., Raeder, B., Efthymiopoulos, T., Buccitelli, C., Segura‐Wang, M., et al. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156505 · Cited by 143
Freyer, M. W., Buscaglia, R., Kaplan, K. A., Cashman, D. J., Hurley, L. H., & Lewis, E. A. S. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.097246 · Cited by 146
Discovering novel chemotherapeutic drugs for the third millennium
Garrett, M. D., & Workman, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00280-4 · Cited by 151
Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer
Hahn, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.018 · Cited by 143
Self-citationTherapeutic Targeting of Telomerase
Jäger, K., & Walter, M. (2016) · Genes · doi:10.3390/genes7070039 · Cited by 139
Telomerase activation, cellular immortalization and cancer
Hahn, W. C., & Meyerson, M. (2001) · Annals of Medicine · doi:10.3109/07853890109002067 · Cited by 142
Self-citationTargeting the Limitless Replicative Potential of Cancer: The Telomerase/Telomere Pathway
Kelland, L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0422 · Cited by 141
Protein phosphatase 2A regulatory subunits and cancer
Eichhorn, P. J. A., Creyghton, M. P., & Bernards, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.005 · Cited by 513
Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R. G., & Gudkov, A. V. (2006) · Genes & Development · doi:10.1101/gad.1372606 · Cited by 152
A genetically tractable model of human glioma formation.
Rich, J. N., Guo, C., McLendon, R. E., Bigner, D. D., Wang, X., & Counter, C. M. (2001) · PubMed · Cited by 141
Self-citationIs There a Role for SV40 in Human Cancer?
Poulin, D. L., & DeCaprio, J. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7101 · Cited by 138
Mechanism of acridine-based telomerase inhibition and telomere shortening
Gunaratnam, M., Greciano, O., Martins, C., Reszka, A. P., Schultes, C. M., Morjani, H., Riou, J., & Neidle, S. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.011 · Cited by 151
Geroconversion: irreversible step to cellular senescence
Blagosklonny, M. V. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985507 · Cited by 138
Bmi-1 Is Essential for the Tumorigenicity of Neuroblastoma Cells
Cui, H., Hu, B., Li, T., Ma, J., Alam, G. N., Gunning, W. T., & Ding, H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060754 · Cited by 140
Kim, M. M., Rivera, M. A., Botchkina, I. L., Shalaby, R., Thor, A. D., & Blackburn, E. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131211098 · Cited by 138
Vial, E., & Marshall, C. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00812 · Cited by 138
Update on Human Polyomaviruses and Cancer
Gjoerup, O. V., & Chang, Y. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)06001-x · Cited by 159
Kawano, Y., Kobune, M., Yamaguchi, M., Nakamura, K., Ito, Y., Sasaki, K., Takahashi, S., Nakamura, T., Chiba, H., Sato, T., et al. (2002) · Blood · doi:10.1182/blood-2002-04-1268 · Cited by 145
Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation
Deneen, B., & Denny, C. T. (2001) · Oncogene · doi:10.1038/sj.onc.1204875 · Cited by 144
Karyotypic Determinants of Chromosome Instability in Aneuploid Budding Yeast
Zhu, J., Pavelka, N., Bradford, W. D., Rancati, G., & Li, R. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002719 · Cited by 136
Carney, S. A., Tahara, H., Swartz, C. D., Risinger, J. I., He, H., Moore, A. B., Haseman, J. K., Barrett, J. C., & Dixon, D. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000017499.51216.3e · Cited by 142
Young, T. W., Mei, F. C., Yang, G., Thompson-Lanza, J. A., Liu, J., & Cheng, X. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0222 · Cited by 136
Identification of Two RNA-binding Proteins Associated with Human Telomerase RNA
Le, S., Sternglanz, R., & Greider, C. W. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.3.999 · Cited by 136
Merkel Cell Polyomavirus Large T Antigen Has Growth-Promoting and Inhibitory Activities
Cheng, J., Rozenblatt–Rosen, O., Paulson, K. G., Nghiem, P., & DeCaprio, J. A. (2013) · Journal of Virology · doi:10.1128/jvi.00385-13 · Cited by 152
Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Kraemer, K., Fuessel, S., Schmidt, U., Kotzsch, M., Schwenzer, B., Wirth, M. P., & Meye, A. (2003) · PubMed · Cited by 145
Kaposi's Sarcoma–Associated Herpesvirus Confers a Survival Advantage to Endothelial Cells
Wang, L., & Damania, B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5988 · Cited by 141
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
Biroccio, A., Cherfils‐Vicini, J., Augereau, A., Pinte, S., Bauwens, S., Ye, J., Simonet, T., Horard, B., Jamet, K., Cervera, L., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2774 · Cited by 149
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability
Ho, K. C., Zhou, Z., She, Y.-M., Chun, A., Cyr, T. D., & Yang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101273108 · Cited by 134
Telomeres and Telomerase: Implications for Cancer and Aging
Shay, J. W., & Wright, W. E. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0188:tatifc]2.0.co;2 · Cited by 134
Stampfer, M. R., Garbe, J., Levine, G., Lichtsteiner, S., Vasserot, A. P., & Yaswen, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071483998 · Cited by 133
Chow, B. S. M., Chew, E. G. Y., Zhao, C., Bathgate, R. A. D., Hewitson, T. D., & Samuel, C. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042714 · Cited by 134
Masuda, A., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205566 · Cited by 145
Critical Role for SV40 Small-t Antigen in Human Cell Transformation
Yu, J., Boyapati, A., & Rundell, K. (2001) · Virology · doi:10.1006/viro.2001.1204 · Cited by 134
Ovarian cancer: pathology, biology, and disease models
Daniel, G. R. (2009) · Frontiers in bioscience · doi:10.2741/3364 · Cited by 154
Alterations in the Smad pathway in human cancers
Samanta, D., & Datta, P. K. (2011) · Frontiers in bioscience · doi:10.2741/3986 · Cited by 143
Immortalization of primary human prostate epithelial cells by c-Myc
Gil, J., Kerai, P., Lleonart, M., Bernard, D., Cigudosa, J. C., Peters, G., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-4030 · Cited by 105
Chakrabarti, O., Veeraraghavalu, K., Tergaonkar, V., Liu, Y., Androphy, E. J., Stanley, M., & Krishna, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5934-5945.2004 · Cited by 129
Differences in telomere length between homologous chromosomes in humans
Londono-Vallejo, J. A. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.15.3164 · Cited by 130
Genes and pathways downstream of telomerase in melanoma metastasis
Bagheri, S., Nosrati, M., Li, S., Fong, S., Torabian, S., Rangel, J., Moore, D. H., Federman, S., LaPosa, R. R., Baehner, F. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510085103 · Cited by 129
DACH1 Is a Cell Fate Determination Factor That Inhibits Cyclin D1 and Breast Tumor Growth
Wu, K., Li, A., Rao, M., Liu, M., Dailey, V. K., Yang, Y., Vizio, D. D., Wang, C., Lisanti, M. P., Sauter, G., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00268-06 · Cited by 139
Miller, S. J., Lavker, R. M., & Sun, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.07.003 · Cited by 148
Cancer in wildlife: patterns of emergence
Pesavento, P. A., Agnew, D. W., Keel, M. K., & Woolard, K. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0045-0 · Cited by 141
Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging
Zhang, H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20919 · Cited by 128
Bmi-1: At the crossroads of physiological and pathological biology
Bhattacharya, R., Mustafi, S. B., Street, M., Dey, A., & Dwivedi, S. K. D. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2015.04.001 · Cited by 143
Structure, Function, and Mechanism of Progranulin; the Brain and Beyond
Toh, H., Chitramuthu, B. P., Bennett, H. P. J., & Bateman, A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9569-4 · Cited by 146
Mechanisms of chromosome instability in cancers
Jefford, C. E., & Irminger‐Finger, I. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.02.005 · Cited by 157
Metadata
- Authors
- Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 1999-07-29
- Volume
- 400
- Issue
- 6743
- Pages
- 464-468
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1545398558
- Cited by
- 2,345
- References
- 31
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 28 · 2023: 42 · 2022: 36 · 2021: 51 · 2020: 44 · 2019: 55 · 2018: 57 · 2017: 48 · 2016: 72 · 2015: 84 · 2014: 92 · 2013: 98 · 2012: 82
- FWCI
- 85.16
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2026-04-15)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- malignant transformation, telomerase reverse transcriptase, SV40 large T antigen, oncogene cooperation, cell immortalization, human epithelial cells, human fibroblasts
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Adhesion, Cell Division, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, DNA-Binding Proteins, Epithelial Cells, Fibroblasts, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Genes, ras, RNA, Telomere, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.